Pembrolizumab Monotherapy Effective for Rare Melanoma
Pembrolizumab led to a dramatic overall response rate among patients with unresectable desmoplastic melanoma.
MDedge News
source https://www.medscape.com/viewarticle/990945?src=rss
MDedge News
source https://www.medscape.com/viewarticle/990945?src=rss
Comments
Post a Comment